France's financial fraud office launched a raid on Sanofi's headquarters in Paris as part of an investigation into a financing deal provided by French bank Société Générale. The Parquet National ...

Sanofi is bestowing $625 million on its investment arm Sanofi Ventures, seeking to take advantage of a biotech landscape that is light on capital yet still heavy on scientific innovation. The cash ...

LONDON, Sept 4 (Reuters) - Shares in French drugmaker Sanofi (SASY.PA), opens new tab fell more than 10% on Thursday, wiping nearly $13 billion off its market value, after late-stage trial data for ...

Digitization has allowed Sanofi to optimize manufacturing and automate document preparation. And now, the firm predicts that AI will soon help it reduce development and manufacturing timelines by 25%.

IGM Biosciences has halted all oncology programs and faces a significant pipeline upheaval, leading to a greater-than-50% drop in share price. Despite holding substantial liquid assets and a ...

Truist analyst Asthika Goonewardene lowered the firm’s price target on IGM Biosciences (IGMS) to $2 from $12 and keeps a Hold rating on the shares. The firm is citing the company’s announcement that ...

IGM Biosciences announced they are halting the development of two investigational drugs for autoimmune and inflammatory diseases, imvotamab (an IgM-based CD20 X CD3 bispecific antibody T cell engager) ...

IGM Biosciences, Inc. is halting the development of its bispecific antibodies imvotamab and IGM-2644 due to insufficient data from clinical trials, specifically regarding B cell depletion for treating ...

Sanofi is joining its fellow drugmakers in trying to put new restrictions on savings sent to hospitals in a federal drug discount program. A spokesperson for Sanofi confirmed plans to implement a ...